55 related articles for article (PubMed ID: 12096037)
1. The assembly of functional beta(2)-microglobulin-free MHC class I molecules that interact with peptides and CD8(+) T lymphocytes.
Schell TD; Mylin LM; Tevethia SS; Joyce S
Int Immunol; 2002 Jul; 14(7):775-82. PubMed ID: 12096037
[TBL] [Abstract][Full Text] [Related]
2. Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers.
Grotenbreg GM; Roan NR; Guillen E; Meijers R; Wang JH; Bell GW; Starnbach MN; Ploegh HL
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3831-6. PubMed ID: 18245382
[TBL] [Abstract][Full Text] [Related]
3. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules.
Yan J; Parekh VV; Mendez-Fernandez Y; Olivares-Villagómez D; Dragovic S; Hill T; Roopenian DC; Joyce S; Van Kaer L
J Exp Med; 2006 Mar; 203(3):647-59. PubMed ID: 16505142
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo.
Zarling AL; Ficarro SB; White FM; Shabanowitz J; Hunt DF; Engelhard VH
J Exp Med; 2000 Dec; 192(12):1755-62. PubMed ID: 11120772
[TBL] [Abstract][Full Text] [Related]
5. Dual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens.
Xiao Z; Ye Z; Tadwal VS; Shen M; Ren EC
Sci Rep; 2017 Jul; 7(1):5072. PubMed ID: 28698575
[TBL] [Abstract][Full Text] [Related]
6. Qa-2-dependent selection of CD8alpha/alpha T cell receptor alpha/beta(+) cells in murine intestinal intraepithelial lymphocytes.
Das G; Gould DS; Augustine MM; Fragoso G; Sciutto E; Stroynowski I; Van Kaer L; Schust DJ; Ploegh H; Janeway CA
J Exp Med; 2000 Nov; 192(10):1521-8. PubMed ID: 11085754
[TBL] [Abstract][Full Text] [Related]
7. Peptide-independent stabilization of MHC class I molecules breaches cellular quality control.
Hein Z; Uchtenhagen H; Abualrous ET; Saini SK; Janßen L; Van Hateren A; Wiek C; Hanenberg H; Momburg F; Achour A; Elliott T; Springer S; Boulanger D
J Cell Sci; 2014 Jul; 127(Pt 13):2885-97. PubMed ID: 24806963
[TBL] [Abstract][Full Text] [Related]
8. Generation of MHC class I ligands in the secretory and vesicular pathways.
Del Val M; Iborra S; Ramos M; Lázaro S
Cell Mol Life Sci; 2011 May; 68(9):1543-52. PubMed ID: 21387141
[TBL] [Abstract][Full Text] [Related]
9. Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules.
Schott E; Bertho N; Ge Q; Maurice MM; Ploegh HL
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13735-40. PubMed ID: 12374858
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic diversity in MHC class I antigen recognition.
Barbosa CRR; Barton J; Shepherd AJ; Mishto M
Biochem J; 2021 Dec; 478(24):4187-4202. PubMed ID: 34940832
[TBL] [Abstract][Full Text] [Related]
11. Total predicted MHC-I epitope load is inversely associated with population mortality from SARS-CoV-2.
Wilson EA; Hirneise G; Singharoy A; Anderson KS
Cell Rep Med; 2021 Mar; 2(3):100221. PubMed ID: 33649748
[TBL] [Abstract][Full Text] [Related]
12. Validation of novel conditional ligands and large-scale detection of antigen-specific T cells for H-2D
Sundebo Meldgaard T; Viborg N; Suarez Hernandez S; Vazquez Albacete D; Tamhane T; Reker Hadrup S
Sci Rep; 2024 May; 14(1):12292. PubMed ID: 38811654
[TBL] [Abstract][Full Text] [Related]
13. Screening self-peptides for recognition by mouse alloreactive CD8
Son ET; Paul-Heng M; Leong M; Wang C; Hill AE; Denkova M; Purcell AW; Mifsud NA; Sharland AF
STAR Protoc; 2023 Mar; 4(1):101943. PubMed ID: 36525346
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the immunopeptidome in vivo reveals new tumour antigens.
Jaeger AM; Stopfer LE; Ahn R; Sanders EA; Sandel DA; Freed-Pastor WA; Rideout WM; Naranjo S; Fessenden T; Nguyen KB; Winter PS; Kohn RE; Westcott PMK; Schenkel JM; Shanahan SL; Shalek AK; Spranger S; White FM; Jacks T
Nature; 2022 Jul; 607(7917):149-155. PubMed ID: 35705813
[TBL] [Abstract][Full Text] [Related]
15. OMIP-002: Phenotypic analysis of specific human CD8+ T-cells using peptide-MHC class I multimers for any of four epitopes.
Chattopadhyay PK; Roederer M; Price DA
Cytometry A; 2010 Sep; 77(9):821-2. PubMed ID: 20722006
[No Abstract] [Full Text] [Related]
16. Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers.
Reis B; Attig J; Dziadek S; Graefe N; Heller A; Rieder N; Gomes B
Front Immunol; 2024; 15():1285049. PubMed ID: 38455061
[TBL] [Abstract][Full Text] [Related]
17. Ezh2
Zimmerman SM; Nixon SJ; Chen PY; Raj L; Smith SR; Paolini RL; Lin PN; Souroullas GP
Oncogene; 2022 Nov; 41(46):4983-4993. PubMed ID: 36220978
[TBL] [Abstract][Full Text] [Related]
18. Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis.
Ravindranath MH; El Hilali F; Amato-Menker CJ; El Hilali H; Selvan SR; Filippone EJ
Antibodies (Basel); 2022 Sep; 11(3):. PubMed ID: 36134954
[TBL] [Abstract][Full Text] [Related]
19. Forming a complex with MHC class I molecules interferes with mouse CD1d functional expression.
Gourapura RJ; Khan MA; Gallo RM; Shaji D; Liu J; Brutkiewicz RR
PLoS One; 2013; 8(8):e72867. PubMed ID: 24009709
[TBL] [Abstract][Full Text] [Related]
20. HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.
Boucherma R; Kridane-Miledi H; Bouziat R; Rasmussen M; Gatard T; Langa-Vives F; Lemercier B; Lim A; Bérard M; Benmohamed L; Buus S; Rooke R; Lemonnier FA
J Immunol; 2013 Jul; 191(2):583-93. PubMed ID: 23776170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
